{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-04-28", "results": { "skip": 0, "limit": 1, "total": 10014 } }, "results": [ { "safetyreportversion": "4", "safetyreportid": "10005888", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20180508", "reporttype": "1", "serious": "1", "seriousnesslifethreatening": "1", "seriousnesshospitalization": "1", "seriousnessdisabling": "1", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20140313", "receiptdateformat": "102", "receiptdate": "20180307", "fulfillexpeditecriteria": "1", "companynumb": "US-ELI_LILLY_AND_COMPANY-US201403002626", "duplicate": "1", "reportduplicate": { "duplicatesource": "ELI LILLY AND CO", "duplicatenumb": "US-ELI_LILLY_AND_COMPANY-US201403002626" }, "primarysource": { "reportercountry": "US", "qualification": "4" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "54", "patientonsetageunit": "801", "patientweight": "108", "patientsex": "1", "reaction": [ { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Cardiac arrest", "reactionoutcome": "1" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Acute myocardial infarction", "reactionoutcome": "3" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Left atrial dilatation", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Hyponatraemia", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Hypertension", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Coronary artery disease", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Ischaemic cardiomyopathy", "reactionoutcome": "3" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Fatigue", "reactionoutcome": "3" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Ventricular tachycardia", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Ventricular fibrillation", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Heart rate increased", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Cardiac failure acute", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Atrial fibrillation", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Hypogonadism", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Respiratory failure", "reactionoutcome": "1" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Ejection fraction decreased", "reactionoutcome": "3" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Cardiac failure congestive", "reactionoutcome": "3" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Sinus bradycardia", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Coronary artery occlusion", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "21.0", "reactionmeddrapt": "Sleep apnoea syndrome", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "2", "medicinalproduct": "CRESTOR", "drugstructuredosagenumb": "40", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "40 MG, QD", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "102", "drugstartdate": "20101014", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "ROSUVASTATIN CALCIUM" }, "openfda": { "application_number": [ "NDA021366" ], "brand_name": [ "CRESTOR" ], "generic_name": [ "ROSUVASTATIN" ], "manufacturer_name": [ "AstraZeneca Pharmaceuticals LP" ], "product_ndc": [ "0310-7560", "0310-7570", "0310-7580", "0310-7590" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "ROSUVASTATIN CALCIUM" ], "rxcui": [ "859419", "859421", "859424", "859426", "859747", "859749", "859751", "859753" ], "spl_id": [ "afc9b415-ee6f-4905-a281-13e74dcf6ce6" ], "spl_set_id": [ "325a5d0e-9a72-4015-9fcd-1655fb504cee" ], "package_ndc": [ "0310-7560-90", "0310-7570-90", "0310-7580-90", "0310-7590-30" ], "unii": [ "83MVU38M7Q" ] } }, { "drugcharacterization": "2", "medicinalproduct": "ASPIRIN USA", "drugstructuredosagenumb": "325", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "325 MG, QD", "drugadministrationroute": "065", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "102", "drugstartdate": "20101014", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "ASPIRIN" } }, { "drugcharacterization": "2", "medicinalproduct": "IRON", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "UNK, QD", "drugdosageform": "TABLET", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "102", "drugstartdate": "20111031", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "IRON" }, "openfda": { "brand_name": [ "FERRUM METALLICUM 6X", "FERRUM METALLICUM", "REAL SUMMER" ], "generic_name": [ "IRON" ], "manufacturer_name": [ "True Botanica, LLC", "Boiron", "KAYONE" ], "product_ndc": [ "53645-1472", "0220-2055", "0220-2085", "69449-1010", "0220-2051", "0220-2050", "0220-2047", "0220-2046", "0220-2054" ], "product_type": [ "HUMAN OTC DRUG" ], "route": [ "ORAL", "TOPICAL" ], "substance_name": [ "IRON" ], "spl_id": [ "23927d2e-da68-f2b5-e063-6394a90a3b8a", "0a0ce402-1803-62f2-e063-6294a90a9770", "0a0ce624-1a00-85f4-e063-6294a90ac29a", "28d3becf-e4b9-4bcf-e063-6294a90a1327", "f6002c71-2a53-b17b-e053-2995a90a0576", "0a0ce624-19fe-85f4-e063-6294a90ac29a", "0a0cdff5-2760-8938-e063-6294a90ad4fb", "0a0ce402-1802-62f2-e063-6294a90a9770", "f5294c54-6706-bc8d-e053-2a95a90a5567" ], "spl_set_id": [ "2392929c-996b-01e0-e063-6394a90aa2b9", "8591b12c-51c8-9839-e053-2a91aa0aa937", "87372ec7-eacf-90b1-e053-2a91aa0afadf", "63021d49-8720-4e4e-a08f-a5d2f6acfaa5", "859195ed-0b6c-f4fe-e053-2991aa0ad85b", "85917340-1f94-08db-e053-2a91aa0a77c9", "85914cb4-f903-80c6-e053-2a91aa0ae14a", "85912948-19cc-76be-e053-2991aa0a3e5a", "85919b82-39cf-254d-e053-2a91aa0a6150" ], "package_ndc": [ "53645-1472-6", "0220-2055-41", "0220-2085-41", "69449-1010-1", "0220-2051-41", "0220-2050-41", "0220-2047-41", "0220-2046-41", "0220-2054-41" ], "unii": [ "E1UOL152H7" ] } }, { "drugcharacterization": "2", "medicinalproduct": "NITROSTAT", "drugstructuredosagenumb": ".4", "drugstructuredosageunit": "003", "drugdosagetext": "0.4 MG, PRN", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "102", "drugstartdate": "20130826", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "NITROGLYCERIN" }, "openfda": { "application_number": [ "NDA021134" ], "brand_name": [ "NITROSTAT" ], "generic_name": [ "NITROGLYCERIN" ], "manufacturer_name": [ "Viatris Specialty LLC" ], "product_ndc": [ "58151-309", "58151-310", "58151-311" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBLINGUAL" ], "substance_name": [ "NITROGLYCERIN" ], "rxcui": [ "198038", "198039", "198040", "207331", "207346", "207361" ], "spl_id": [ "793962da-82d4-4fe1-b78d-dccf10a8ff85" ], "spl_set_id": [ "9a52da75-d0af-4237-96c0-0b12adfa8636" ], "package_ndc": [ "58151-309-01", "58151-310-01", "58151-310-94", "58151-310-52", "58151-311-01" ], "nui": [ "N0000175415", "M0014874", "N0000009909" ], "pharm_class_epc": [ "Nitrate Vasodilator [EPC]" ], "pharm_class_cs": [ "Nitrates [CS]" ], "pharm_class_pe": [ "Vasodilation [PE]" ], "unii": [ "G59M7S0WS3" ] } }, { "drugcharacterization": "1", "medicinalproduct": "ATENOLOL.", "drugstructuredosagenumb": "25", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "25 MG, QD", "drugadministrationroute": "048", "drugindication": "VENTRICULAR EXTRASYSTOLES", "drugstartdateformat": "102", "drugstartdate": "19990118", "actiondrug": "5", "drugrecurreadministration": "3", "drugadditional": "3", "activesubstance": { "activesubstancename": "ATENOLOL" }, "openfda": { "application_number": [ "NDA018240", "ANDA078512", "ANDA213136", "ANDA077443", "ANDA076900", "ANDA077877", "ANDA073457", "ANDA074056" ], "brand_name": [ "TENORMIN", "ATENOLOL" ], "generic_name": [ "ATENOLOL" ], "manufacturer_name": [ "Almatica Pharma LLC", "Aurobindo Pharma Limited", "Unichem Pharmaceuticals (USA), Inc.", "Rising Pharma Holdings, Inc.", "Zydus Lifesciences Limited", "Upsher-Smith Laboratories, LLC", "Ipca Laboratories Limited", "Mylan Pharmaceuticals Inc.", "Zydus Pharmaceuticals USA Inc.", "Teva Pharmaceuticals USA, Inc." ], "product_ndc": [ "52427-429", "52427-430", "52427-431", "65862-168", "65862-169", "65862-170", "29300-410", "29300-411", "29300-412", "64980-437", "64980-438", "64980-439", "65841-022", "65841-023", "65841-024", "24979-244", "24979-245", "24979-246", "83980-022", "83980-023", "83980-024", "0378-0218", "0378-0231", "0378-0757", "68382-022", "68382-023", "68382-024", "0093-0752", "0093-0787", "0093-0753" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "ATENOLOL" ], "rxcui": [ "150750", "152414", "197379", "197380", "197381", "201322" ], "spl_id": [ "ecd0de7b-801e-a5d6-01b7-01b89a8f3a78", "c5b37783-b0a1-4d21-b0cc-69a13cc4d2db", "b84110b2-cefb-49d0-8b08-1057dbdc258b", "7bf7d854-7736-4159-81e0-2f9f0c12d73c", "f4fb6b85-6379-4e8a-9ee3-402819d128a0", "c804fa73-5b5a-4e20-a1f5-6a13155df21f", "d32b777e-6c64-4899-934b-4fb73d9eba85", "9df3aeb2-2d70-4d49-9b45-a25e3a371cf9", "860eb406-b330-4b72-b768-122d57c74293", "19103c06-1fed-45a4-a110-66465b4f2233" ], "spl_set_id": [ "746db603-a6e1-4dc3-c2d8-92314419098c", "1b8a4689-3916-4f4b-b54a-bbb4e322d79b", "35d99c43-7305-4a4a-886e-a9bf3ee88fa8", "96dd038f-b363-4e24-9c67-82b7c85c3bc4", "2492d5f6-00b0-42c9-a793-2be83ea81ad1", "6e850b1e-28a4-4ff8-8ed7-bb0b29faa28a", "98d29958-b026-4888-a516-7bb85bb7d479", "a7048c81-6769-436b-8397-fbaa7489fcdf", "db801706-1362-44c7-92ab-f584f96c7e1c", "25a72ec9-de0f-44e5-90b8-da1aab0d3588" ], "package_ndc": [ "52427-429-90", "52427-430-90", "52427-431-90", "65862-168-01", "65862-168-99", "65862-169-01", "65862-169-99", "65862-170-01", "65862-170-99", "29300-410-01", "29300-410-05", "29300-410-10", "29300-411-05", "29300-411-01", "29300-411-10", "29300-412-01", "29300-412-05", "29300-412-10", "64980-437-01", "64980-437-10", "64980-438-01", "64980-438-10", "64980-439-01", "64980-439-10", "65841-022-16", "65841-022-01", "65841-022-10", "65841-022-40", "65841-022-24", "65841-023-16", "65841-023-01", "65841-023-10", "65841-023-02", "65841-023-40", "65841-023-24", "65841-024-01", "65841-024-10", "65841-024-40", "65841-024-16", "24979-244-07", "24979-245-07", "24979-246-07", "83980-022-97", "83980-022-01", "83980-022-10", "83980-023-97", "83980-023-01", "83980-023-10", "83980-024-97", "83980-024-01", "83980-024-10", "0378-0218-01", "0378-0218-10", "0378-0231-01", "0378-0231-10", "0378-0757-01", "0378-0757-10", "68382-022-16", "68382-022-01", "68382-022-10", "68382-022-40", "68382-022-24", "68382-023-16", "68382-023-01", "68382-023-10", "68382-023-02", "68382-023-40", "68382-023-24", "68382-024-16", "68382-024-01", "68382-024-10", "68382-024-40", "0093-0787-01", "0093-0787-10", "0093-0752-01", "0093-0752-10", "0093-0753-01", "0093-0753-05" ], "nui": [ "N0000000161", "N0000175556" ], "pharm_class_moa": [ "Adrenergic beta-Antagonists [MoA]" ], "pharm_class_epc": [ "beta-Adrenergic Blocker [EPC]" ], "unii": [ "50VV3VW0TI" ] } }, { "drugcharacterization": "1", "medicinalproduct": "LASIX", "drugstructuredosagenumb": "40", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "3", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "UNK, UNKNOWN", "drugadministrationroute": "042", "drugindication": "CARDIAC FAILURE", "drugstartdateformat": "102", "drugstartdate": "20130730", "actiondrug": "1", "drugrecurreadministration": "3", "drugadditional": "1", "activesubstance": { "activesubstancename": "FUROSEMIDE" }, "openfda": { "application_number": [ "NDA016273" ], "brand_name": [ "LASIX" ], "generic_name": [ "FUROSEMIDE" ], "manufacturer_name": [ "Validus Pharmaceuticals LLC" ], "product_ndc": [ "30698-060", "30698-067", "30698-066" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "FUROSEMIDE" ], "rxcui": [ "197732", "200801", "200809", "205732", "310429", "313988" ], "spl_id": [ "4002943d-0b4b-4ff0-e063-6394a90ae63b" ], "spl_set_id": [ "2c9b4d8f-0770-482d-a9e6-9c616a440b1a" ], "package_ndc": [ "30698-067-01", "30698-067-10", "30698-060-01", "30698-060-10", "30698-060-50", "30698-066-05", "30698-066-50" ], "nui": [ "N0000175366", "N0000175590" ], "pharm_class_pe": [ "Increased Diuresis at Loop of Henle [PE]" ], "pharm_class_epc": [ "Loop Diuretic [EPC]" ], "unii": [ "7LXU5N7ZO5" ] } }, { "drugcharacterization": "1", "medicinalproduct": "AXIRON", "drugauthorizationnumb": "022504", "drugstructuredosagenumb": "60", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "60 MG, QD", "drugdosageform": "SOLUTION", "drugadministrationroute": "061", "drugindication": "ANDROGEN DEFICIENCY", "drugstartdateformat": "102", "drugstartdate": "20111010", "actiondrug": "2", "drugadditional": "1", "activesubstance": { "activesubstancename": "TESTOSTERONE" } }, { "drugcharacterization": "1", "medicinalproduct": "AXIRON", "drugauthorizationnumb": "022504", "drugstructuredosagenumb": "90", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "90 MG, QD", "drugdosageform": "SOLUTION", "drugadministrationroute": "061", "drugstartdateformat": "102", "drugstartdate": "20130625", "actiondrug": "2", "drugadditional": "1", "activesubstance": { "activesubstancename": "TESTOSTERONE" } }, { "drugcharacterization": "2", "medicinalproduct": "NORPACE", "drugstructuredosagenumb": "150", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "150 MG, QD", "drugadministrationroute": "065", "drugindication": "VENTRICULAR EXTRASYSTOLES", "drugstartdateformat": "102", "drugstartdate": "19990118", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "DISOPYRAMIDE PHOSPHATE" }, "openfda": { "application_number": [ "NDA017447" ], "brand_name": [ "NORPACE" ], "generic_name": [ "DISOPYRAMIDE PHOSPHATE" ], "manufacturer_name": [ "Pfizer Laboratories Div Pfizer Inc" ], "product_ndc": [ "0025-2752", "0025-2762", "0025-2732", "0025-2742" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DISOPYRAMIDE PHOSPHATE" ], "rxcui": [ "209066", "209692", "309958", "309960", "636793", "636794", "902648", "902652" ], "spl_id": [ "acc7751f-7484-4d53-8a6b-0194f23da1c8" ], "spl_set_id": [ "e2aa1642-d262-4520-bc6a-9fd3ad795677" ], "package_ndc": [ "0025-2752-31", "0025-2762-31", "0025-2732-31", "0025-2742-31" ], "unii": [ "N6BOM1935W" ] } }, { "drugcharacterization": "2", "medicinalproduct": "NIASPAN", "drugstructuredosagenumb": "150", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "150 MG, QD", "drugadministrationroute": "048", "drugindication": "HYPERLIPIDAEMIA", "drugstartdateformat": "102", "drugstartdate": "20101014", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "NIACIN" } }, { "drugcharacterization": "2", "medicinalproduct": "PRADAXA", "drugstructuredosagenumb": "75", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "2", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "75 MG, BID", "drugadministrationroute": "065", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "102", "drugstartdate": "20111208", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "DABIGATRAN ETEXILATE MESYLATE" }, "openfda": { "application_number": [ "NDA022512", "NDA214358" ], "brand_name": [ "PRADAXA" ], "generic_name": [ "DABIGATRAN ETEXILATE MESYLATE", "DABIGATRAN ETEXILATE" ], "manufacturer_name": [ "Boehringer Ingelheim Pharmaceuticals Inc.", "Boehringer Ingelheim Pharmaceuticals, Inc." ], "product_ndc": [ "0597-0108", "0597-0355", "0597-0360", "0597-0425", "0597-0430", "0597-0435", "0597-0440", "0597-0445", "0597-0450" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DABIGATRAN ETEXILATE MESYLATE" ], "rxcui": [ "1037045", "1037049", "1037179", "1037181", "1723476", "1723478", "2590616", "2590619", "2590620", "2590621", "2590623", "2590625", "2590627", "2590629", "2590631", "2590633", "2590635", "2590637" ], "spl_id": [ "ecf1aa06-c610-4fdb-a380-2e716d7e63c2", "56b1a7c2-0afd-40c6-bda5-563e234a9f28" ], "spl_set_id": [ "ba74e3cd-b06f-4145-b284-5fd6b84ff3c9", "9ac0a64a-8666-45f7-9d4f-40fd894f7e6d" ], "package_ndc": [ "0597-0108-54", "0597-0108-60", "0597-0355-09", "0597-0355-56", "0597-0355-53", "0597-0360-55", "0597-0360-42", "0597-0360-82", "0597-0425-78", "0597-0430-18", "0597-0435-96", "0597-0440-53", "0597-0445-87", "0597-0450-16" ], "unii": [ "SC7NUW5IIT" ] } }, { "drugcharacterization": "2", "medicinalproduct": "PLAVIX", "drugstructuredosagenumb": "75", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "75 MG, QD", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "102", "drugstartdate": "20130826", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "CLOPIDOGREL BISULFATE" }, "openfda": { "application_number": [ "NDA020839" ], "brand_name": [ "PLAVIX" ], "generic_name": [ "CLOPIDOGREL" ], "manufacturer_name": [ "Sanofi-Aventis U.S. LLC" ], "product_ndc": [ "0024-1171", "0024-1332" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "CLOPIDOGREL BISULFATE" ], "rxcui": [ "213169", "309362", "749196", "749198" ], "spl_id": [ "ed60a9e7-49f4-469c-bb7a-08e1bb6057e2" ], "spl_set_id": [ "de8b0b67-eb25-4684-83b5-7ad785314227" ], "package_ndc": [ "0024-1171-90", "0024-1332-30" ], "unii": [ "08I79HTP27" ] } }, { "drugcharacterization": "1", "medicinalproduct": "LASIX", "drugdosagetext": "UNK, UNKNOWN", "drugadministrationroute": "048", "actiondrug": "1", "drugrecurreadministration": "3", "drugadditional": "1", "activesubstance": { "activesubstancename": "FUROSEMIDE" }, "openfda": { "application_number": [ "NDA016273" ], "brand_name": [ "LASIX" ], "generic_name": [ "FUROSEMIDE" ], "manufacturer_name": [ "Validus Pharmaceuticals LLC" ], "product_ndc": [ "30698-060", "30698-067", "30698-066" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "FUROSEMIDE" ], "rxcui": [ "197732", "200801", "200809", "205732", "310429", "313988" ], "spl_id": [ "4002943d-0b4b-4ff0-e063-6394a90ae63b" ], "spl_set_id": [ "2c9b4d8f-0770-482d-a9e6-9c616a440b1a" ], "package_ndc": [ "30698-067-01", "30698-067-10", "30698-060-01", "30698-060-10", "30698-060-50", "30698-066-05", "30698-066-50" ], "nui": [ "N0000175366", "N0000175590" ], "pharm_class_pe": [ "Increased Diuresis at Loop of Henle [PE]" ], "pharm_class_epc": [ "Loop Diuretic [EPC]" ], "unii": [ "7LXU5N7ZO5" ] } }, { "drugcharacterization": "2", "medicinalproduct": "CIALIS", "drugstructuredosagenumb": "10", "drugstructuredosageunit": "003", "drugdosagetext": "10 MG, PRN", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "102", "drugstartdate": "20101014", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "TADALAFIL" }, "openfda": { "application_number": [ "NDA021368" ], "brand_name": [ "CIALIS" ], "generic_name": [ "TADALAFIL" ], "manufacturer_name": [ "Eli Lilly and Company" ], "product_ndc": [ "0002-4462", "0002-4463", "0002-4464" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "TADALAFIL" ], "rxcui": [ "402019", "402096", "402097", "403957", "404711", "484814" ], "spl_id": [ "0850d8e6-3c38-484d-990c-fd2780b46454" ], "spl_set_id": [ "bcd8f8ab-81a2-4891-83db-24a0b0e25895" ], "package_ndc": [ "0002-4462-30", "0002-4463-30", "0002-4464-30" ], "nui": [ "N0000175599", "N0000020026" ], "pharm_class_epc": [ "Phosphodiesterase 5 Inhibitor [EPC]" ], "pharm_class_moa": [ "Phosphodiesterase 5 Inhibitors [MoA]" ], "unii": [ "742SXX0ICT" ] } }, { "drugcharacterization": "2", "medicinalproduct": "VITAMIN D /00107901/", "drugstructuredosagenumb": "5000", "drugstructuredosageunit": "025", "drugseparatedosagenumb": "2", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "803", "drugdosagetext": "5000 IU, 2/W", "drugadministrationroute": "065", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "102", "drugstartdate": "20111031", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "ERGOCALCIFEROL" } }, { "drugcharacterization": "1", "medicinalproduct": "AMIODARONE", "drugdosagetext": "UNK, UNKNOWN", "drugadministrationroute": "065", "drugindication": "VENTRICULAR TACHYCARDIA", "drugstartdateformat": "102", "drugstartdate": "20130730", "actiondrug": "5", "drugrecurreadministration": "3", "drugadditional": "3", "activesubstance": { "activesubstancename": "AMIODARONE" } }, { "drugcharacterization": "1", "medicinalproduct": "AXIRON", "drugauthorizationnumb": "022504", "drugstructuredosagenumb": "90", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "803", "drugdosagetext": "90 MG, WEEKLY (1/W)", "drugdosageform": "SOLUTION", "drugadministrationroute": "061", "actiondrug": "2", "drugadditional": "1", "activesubstance": { "activesubstancename": "TESTOSTERONE" } }, { "drugcharacterization": "1", "medicinalproduct": "ANDROGEL", "drugstructuredosagenumb": "5", "drugstructuredosageunit": "002", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugcumulativedosagenumb": "30", "drugcumulativedosageunit": "002", "drugdosagetext": "5 G, QD", "drugadministrationroute": "061", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "102", "drugstartdate": "20130725", "drugenddateformat": "102", "drugenddate": "20131017", "actiondrug": "1", "drugrecurreadministration": "3", "drugadditional": "1", "activesubstance": { "activesubstancename": "TESTOSTERONE" }, "openfda": { "application_number": [ "NDA021015", "NDA022309" ], "brand_name": [ "ANDROGEL" ], "generic_name": [ "TESTOSTERONE" ], "manufacturer_name": [ "ASCEND Therapeutics U.S., LLC" ], "product_ndc": [ "17139-501", "17139-525", "17139-550", "17139-562" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "TRANSDERMAL" ], "substance_name": [ "TESTOSTERONE" ], "rxcui": [ "1596780", "1597074", "1597123", "1597124", "1597129", "1597130", "1597075", "1597076", "1597120", "1597121", "1597126", "1597127" ], "spl_id": [ "14a12387-5802-4ec9-8a75-85faebddd18c", "130cc5ce-2385-4630-a8a1-2767bb1e0575" ], "spl_set_id": [ "f4e8fc4e-d6ba-2783-e053-2a95a90a7ae7", "f4e8d29b-8707-4d47-e053-2a95a90aecee" ], "package_ndc": [ "17139-501-02", "17139-525-30", "17139-550-30", "17139-562-88", "17139-562-12", "17139-562-31", "17139-562-01", "17139-562-30" ], "nui": [ "N0000175824", "N0000000146", "M0001109" ], "pharm_class_epc": [ "Androgen [EPC]" ], "pharm_class_moa": [ "Androgen Receptor Agonists [MoA]" ], "pharm_class_cs": [ "Androstanes [CS]" ], "unii": [ "3XMK78S47O" ] } }, { "drugcharacterization": "1", "medicinalproduct": "ATENOLOL.", "drugindication": "PRESYNCOPE", "actiondrug": "5", "drugrecurreadministration": "3", "drugadditional": "3", "activesubstance": { "activesubstancename": "ATENOLOL" }, "openfda": { "application_number": [ "NDA018240", "ANDA078512", "ANDA213136", "ANDA077443", "ANDA076900", "ANDA077877", "ANDA073457", "ANDA074056" ], "brand_name": [ "TENORMIN", "ATENOLOL" ], "generic_name": [ "ATENOLOL" ], "manufacturer_name": [ "Almatica Pharma LLC", "Aurobindo Pharma Limited", "Unichem Pharmaceuticals (USA), Inc.", "Rising Pharma Holdings, Inc.", "Zydus Lifesciences Limited", "Upsher-Smith Laboratories, LLC", "Ipca Laboratories Limited", "Mylan Pharmaceuticals Inc.", "Zydus Pharmaceuticals USA Inc.", "Teva Pharmaceuticals USA, Inc." ], "product_ndc": [ "52427-429", "52427-430", "52427-431", "65862-168", "65862-169", "65862-170", "29300-410", "29300-411", "29300-412", "64980-437", "64980-438", "64980-439", "65841-022", "65841-023", "65841-024", "24979-244", "24979-245", "24979-246", "83980-022", "83980-023", "83980-024", "0378-0218", "0378-0231", "0378-0757", "68382-022", "68382-023", "68382-024", "0093-0752", "0093-0787", "0093-0753" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "ATENOLOL" ], "rxcui": [ "150750", "152414", "197379", "197380", "197381", "201322" ], "spl_id": [ "ecd0de7b-801e-a5d6-01b7-01b89a8f3a78", "c5b37783-b0a1-4d21-b0cc-69a13cc4d2db", "b84110b2-cefb-49d0-8b08-1057dbdc258b", "7bf7d854-7736-4159-81e0-2f9f0c12d73c", "f4fb6b85-6379-4e8a-9ee3-402819d128a0", "c804fa73-5b5a-4e20-a1f5-6a13155df21f", "d32b777e-6c64-4899-934b-4fb73d9eba85", "9df3aeb2-2d70-4d49-9b45-a25e3a371cf9", "860eb406-b330-4b72-b768-122d57c74293", "19103c06-1fed-45a4-a110-66465b4f2233" ], "spl_set_id": [ "746db603-a6e1-4dc3-c2d8-92314419098c", "1b8a4689-3916-4f4b-b54a-bbb4e322d79b", "35d99c43-7305-4a4a-886e-a9bf3ee88fa8", "96dd038f-b363-4e24-9c67-82b7c85c3bc4", "2492d5f6-00b0-42c9-a793-2be83ea81ad1", "6e850b1e-28a4-4ff8-8ed7-bb0b29faa28a", "98d29958-b026-4888-a516-7bb85bb7d479", "a7048c81-6769-436b-8397-fbaa7489fcdf", "db801706-1362-44c7-92ab-f584f96c7e1c", "25a72ec9-de0f-44e5-90b8-da1aab0d3588" ], "package_ndc": [ "52427-429-90", "52427-430-90", "52427-431-90", "65862-168-01", "65862-168-99", "65862-169-01", "65862-169-99", "65862-170-01", "65862-170-99", "29300-410-01", "29300-410-05", "29300-410-10", "29300-411-05", "29300-411-01", "29300-411-10", "29300-412-01", "29300-412-05", "29300-412-10", "64980-437-01", "64980-437-10", "64980-438-01", "64980-438-10", "64980-439-01", "64980-439-10", "65841-022-16", "65841-022-01", "65841-022-10", "65841-022-40", "65841-022-24", "65841-023-16", "65841-023-01", "65841-023-10", "65841-023-02", "65841-023-40", "65841-023-24", "65841-024-01", "65841-024-10", "65841-024-40", "65841-024-16", "24979-244-07", "24979-245-07", "24979-246-07", "83980-022-97", "83980-022-01", "83980-022-10", "83980-023-97", "83980-023-01", "83980-023-10", "83980-024-97", "83980-024-01", "83980-024-10", "0378-0218-01", "0378-0218-10", "0378-0231-01", "0378-0231-10", "0378-0757-01", "0378-0757-10", "68382-022-16", "68382-022-01", "68382-022-10", "68382-022-40", "68382-022-24", "68382-023-16", "68382-023-01", "68382-023-10", "68382-023-02", "68382-023-40", "68382-023-24", "68382-024-16", "68382-024-01", "68382-024-10", "68382-024-40", "0093-0787-01", "0093-0787-10", "0093-0752-01", "0093-0752-10", "0093-0753-01", "0093-0753-05" ], "nui": [ "N0000000161", "N0000175556" ], "pharm_class_moa": [ "Adrenergic beta-Antagonists [MoA]" ], "pharm_class_epc": [ "beta-Adrenergic Blocker [EPC]" ], "unii": [ "50VV3VW0TI" ] } }, { "drugcharacterization": "2", "medicinalproduct": "CYMBALTA", "drugstructuredosagenumb": "60", "drugstructuredosageunit": "003", "drugdosagetext": "60 MG, UNK", "drugadministrationroute": "048", "drugindication": "DEPRESSION", "drugstartdateformat": "102", "drugstartdate": "20101014", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "DULOXETINE HYDROCHLORIDE" }, "openfda": { "application_number": [ "NDA021427" ], "brand_name": [ "CYMBALTA" ], "generic_name": [ "DULOXETINE HYDROCHLORIDE" ], "manufacturer_name": [ "Eli Lilly and Company" ], "product_ndc": [ "0002-3235", "0002-3240", "0002-3270" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DULOXETINE HYDROCHLORIDE" ], "rxcui": [ "596926", "596928", "596930", "596932", "596934", "615186" ], "spl_id": [ "aa5061b1-f237-425a-9d05-575c333dfd37" ], "spl_set_id": [ "2f7d4d67-10c1-4bf4-a7f2-c185fbad64ba" ], "package_ndc": [ "0002-3235-60", "0002-3240-30", "0002-3240-90", "0002-3270-30" ], "unii": [ "9044SC542W" ] } }, { "drugcharacterization": "2", "medicinalproduct": "WELLBUTRIN", "drugstructuredosagenumb": "150", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "150 MG, QD", "drugadministrationroute": "065", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "102", "drugstartdate": "20101014", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "BUPROPION HYDROCHLORIDE" }, "openfda": { "application_number": [ "NDA021515", "NDA020358" ], "brand_name": [ "WELLBUTRIN XL", "WELLBUTRIN SR" ], "generic_name": [ "BUPROPION HYDROCHLORIDE" ], "manufacturer_name": [ "Bausch Health US LLC", "GlaxoSmithKline LLC" ], "product_ndc": [ "0187-0730", "0187-0731", "0173-0135", "0173-0947", "0173-0722" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "BUPROPION HYDROCHLORIDE" ], "rxcui": [ "993541", "993545", "993557", "993564", "993503", "993511", "993518", "993528", "993536", "993537" ], "spl_id": [ "22308f71-fc56-430d-b559-bed47e17a46c", "5ffc8b63-7d69-4f3a-bf05-a9c138724a91" ], "spl_set_id": [ "a435da9d-f6e8-4ddc-897d-8cd2bf777b21", "cbc8c074-f080-4489-a5ae-207b5fadeba3" ], "package_ndc": [ "0187-0730-30", "0187-0730-90", "0187-0730-07", "0187-0731-30", "0187-0731-07", "0173-0947-55", "0173-0135-55", "0173-0722-00" ], "unii": [ "ZG7E5POY8O" ] } }, { "drugcharacterization": "2", "medicinalproduct": "SYNTHROID", "drugstructuredosagenumb": "88", "drugstructuredosageunit": "004", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "88 UG, QD", "drugadministrationroute": "065", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "102", "drugstartdate": "20101014", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "LEVOTHYROXINE SODIUM" }, "openfda": { "application_number": [ "NDA021402" ], "brand_name": [ "SYNTHROID" ], "generic_name": [ "LEVOTHYROXINE SODIUM" ], "manufacturer_name": [ "AbbVie Inc." ], "product_ndc": [ "0074-3727", "0074-4341", "0074-4552", "0074-5182", "0074-6594", "0074-6624", "0074-9296", "0074-7068", "0074-7069", "0074-7070", "0074-7148", "0074-7149" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "LEVOTHYROXINE SODIUM" ], "rxcui": [ "892246", "892251", "892255", "966158", "966171", "966185", "966191", "966201", "966205", "966218", "966220", "966221", "966222", "966224", "966225", "966247", "966248", "966249", "966250", "966251", "966253", "966270", "966271", "966282" ], "spl_id": [ "b85ab7fa-ba96-43cd-b736-44b3924e644c" ], "spl_set_id": [ "1e11ad30-1041-4520-10b0-8f9d30d30fcc" ], "package_ndc": [ "0074-4341-13", "0074-4341-90", "0074-4341-19", "0074-4341-72", "0074-4552-13", "0074-4552-90", "0074-4552-19", "0074-4552-11", "0074-4552-71", "0074-4552-72", "0074-5182-13", "0074-5182-90", "0074-5182-71", "0074-5182-19", "0074-5182-11", "0074-5182-72", "0074-6594-13", "0074-6594-90", "0074-6594-71", "0074-6594-19", "0074-6594-72", "0074-6624-13", "0074-6624-90", "0074-6624-19", "0074-6624-11", "0074-6624-71", "0074-6624-72", "0074-9296-13", "0074-9296-90", "0074-9296-19", "0074-9296-71", "0074-9296-72", "0074-7068-13", "0074-7068-90", "0074-7068-71", "0074-7068-19", "0074-7068-11", "0074-7068-72", "0074-3727-13", "0074-3727-90", "0074-3727-71", "0074-3727-19", "0074-3727-72", "0074-7069-90", "0074-7069-71", "0074-7069-19", "0074-7069-11", "0074-7069-72", "0074-7070-13", "0074-7070-90", "0074-7070-71", "0074-7070-19", "0074-7070-72", "0074-7148-90", "0074-7148-19", "0074-7148-71", "0074-7148-11", "0074-7148-72", "0074-7149-90", "0074-7149-19" ], "unii": [ "9J765S329G" ] } }, { "drugcharacterization": "2", "medicinalproduct": "MULTAQ", "drugstructuredosagenumb": "400", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "2", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "400 MG, BID", "drugadministrationroute": "048", "drugindication": "ATRIAL FIBRILLATION", "drugstartdateformat": "102", "drugstartdate": "20111122", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "DRONEDARONE" }, "openfda": { "application_number": [ "NDA022425" ], "brand_name": [ "MULTAQ" ], "generic_name": [ "DRONEDARONE" ], "manufacturer_name": [ "Sanofi-Aventis U.S. LLC" ], "product_ndc": [ "0024-4142" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DRONEDARONE" ], "rxcui": [ "854856", "854859" ], "spl_id": [ "badf58f9-01fe-4900-be06-784029a72151" ], "spl_set_id": [ "7fa41601-7fb5-4155-8e50-2ae903f0d2d6" ], "package_ndc": [ "0024-4142-60", "0024-4142-50", "0024-4142-10", "0024-4142-00", "0024-4142-06" ], "nui": [ "N0000175426" ], "pharm_class_epc": [ "Antiarrhythmic [EPC]" ], "unii": [ "JQZ1L091Y2" ] } }, { "drugcharacterization": "2", "medicinalproduct": "COREG", "drugseparatedosagenumb": "2", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "UNK, BID", "drugadministrationroute": "065", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "102", "drugstartdate": "20130826", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "CARVEDILOL" }, "openfda": { "application_number": [ "NDA020297" ], "brand_name": [ "COREG" ], "generic_name": [ "CARVEDILOL" ], "manufacturer_name": [ "Waylis Therapeutics LLC" ], "product_ndc": [ "80725-139", "80725-140", "80725-141", "80725-142" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "CARVEDILOL" ], "rxcui": [ "200031", "200032", "200033", "212388", "212389", "212390", "686924", "686926" ], "spl_id": [ "f2798247-00df-4ec2-a6f8-1902f10b5558" ], "spl_set_id": [ "07c619c6-4a0c-445e-94fa-664a54f68a39" ], "package_ndc": [ "80725-139-20", "80725-140-20", "80725-141-20", "80725-142-20" ], "nui": [ "N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556" ], "pharm_class_moa": [ "Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]" ], "pharm_class_epc": [ "alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]" ], "unii": [ "0K47UL67F2" ] } } ], "summary": { "narrativeincludeclinical": "CASE EVENT DATE: 2011" } } } ] }